Processing of Innovative A2 milk/milkshakes for distribution

创新 A2 牛奶/奶昔加工以供分销

基本信息

  • 批准号:
    10046690
  • 负责人:
  • 金额:
    $ 6.07万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Grant for R&D
  • 财政年份:
    2022
  • 资助国家:
    英国
  • 起止时间:
    2022 至 无数据
  • 项目状态:
    已结题

项目摘要

The assumption that is commonly made is that someone who experiences digestive symptoms after consuming dairy products they are lactose intolerant and informed to alter their eating to abide with a low-dairy or dairy-free diet. However, this is not always the case. Milk allergies are caused by the proteins in the dairy products and as such A1 Protein intolerance can often be misdiagnosed as lactose intolerance as the symptoms are similar. However, the key difference is that milk allergies (A1 protein intolerance) usually appear within the first year of life while lactose intolerance typically appears much later. (A2 Milk Nutrition, 2021)The Parlour Annalong have identified this and the owner who is also a dairy farmer has bred cows only containing the A2 protein for the past 8 years. As a result of this, the milk that the Parlour purchases from the farm contains only A2 protein and is therefore suitable for those that have an A1 intolerance. The project is to source funding to purchase the equipment necessary to process the milk purchased from the farm into drinkable milk/milkshakes suitable for distribution to shops as well as for sales in The Parlour's café. This enables the local community and visitors to avail of this if they are A1 protein intolerant while they visit the Parlours café. As well as this, the grocery shops and newsagents that the Parlour plan to distribute to will spread the product diversely across Northern Ireland and as such the product reach will not just be limited to the café and surrounding shops in that area.
通常的假设是,有人在食用乳制品后出现消化症状,他们是乳糖不耐症,并被告知改变饮食以遵守低乳制品或无乳制品饮食。然而,情况并非总是如此。牛奶过敏是由乳制品中的蛋白质引起的,因此A1蛋白质不耐受通常会被误诊为乳糖不耐受,因为症状相似。然而,关键的区别是牛奶过敏(A1蛋白不耐受)通常出现在生命的第一年,而乳糖不耐受通常出现得更晚。(A2牛奶营养,2021年)客厅安娜龙已经确定了这一点,业主谁也是一个奶农饲养的奶牛只含有A2蛋白在过去的8年。因此,Parlour从农场购买的牛奶只含有A2蛋白,因此适合那些对A1不耐受的人。该项目旨在筹集资金,购买必要的设备,将从农场购买的牛奶加工成适合分发给商店以及在The Parlour咖啡馆销售的饮用牛奶/奶昔。这使当地社区和游客能够利用这一点,如果他们是A1蛋白不耐受,而他们访问的Parlours咖啡馆。除此之外,Parlour计划分销的杂货店和报摊将把产品分销到北方爱尔兰,因此产品的覆盖范围将不仅限于该地区的咖啡馆和周边商店。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

其他文献

吉治仁志 他: "トランスジェニックマウスによるTIMP-1の線維化促進機序"最新医学. 55. 1781-1787 (2000)
Hitoshi Yoshiji 等:“转基因小鼠中 TIMP-1 的促纤维化机制”现代医学 55. 1781-1787 (2000)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
LiDAR Implementations for Autonomous Vehicle Applications
  • DOI:
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
生命分子工学・海洋生命工学研究室
生物分子工程/海洋生物技术实验室
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
吉治仁志 他: "イラスト医学&サイエンスシリーズ血管の分子医学"羊土社(渋谷正史編). 125 (2000)
Hitoshi Yoshiji 等人:“血管医学与科学系列分子医学图解”Yodosha(涉谷正志编辑)125(2000)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Effect of manidipine hydrochloride,a calcium antagonist,on isoproterenol-induced left ventricular hypertrophy: "Yoshiyama,M.,Takeuchi,K.,Kim,S.,Hanatani,A.,Omura,T.,Toda,I.,Akioka,K.,Teragaki,M.,Iwao,H.and Yoshikawa,J." Jpn Circ J. 62(1). 47-52 (1998)
钙拮抗剂盐酸马尼地平对异丙肾上腺素引起的左心室肥厚的影响:“Yoshiyama,M.,Takeuchi,K.,Kim,S.,Hanatani,A.,Omura,T.,Toda,I.,Akioka,
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:

的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('', 18)}}的其他基金

An implantable biosensor microsystem for real-time measurement of circulating biomarkers
用于实时测量循环生物标志物的植入式生物传感器微系统
  • 批准号:
    2901954
  • 财政年份:
    2028
  • 资助金额:
    $ 6.07万
  • 项目类别:
    Studentship
Exploiting the polysaccharide breakdown capacity of the human gut microbiome to develop environmentally sustainable dishwashing solutions
利用人类肠道微生物群的多糖分解能力来开发环境可持续的洗碗解决方案
  • 批准号:
    2896097
  • 财政年份:
    2027
  • 资助金额:
    $ 6.07万
  • 项目类别:
    Studentship
A Robot that Swims Through Granular Materials
可以在颗粒材料中游动的机器人
  • 批准号:
    2780268
  • 财政年份:
    2027
  • 资助金额:
    $ 6.07万
  • 项目类别:
    Studentship
Likelihood and impact of severe space weather events on the resilience of nuclear power and safeguards monitoring.
严重空间天气事件对核电和保障监督的恢复力的可能性和影响。
  • 批准号:
    2908918
  • 财政年份:
    2027
  • 资助金额:
    $ 6.07万
  • 项目类别:
    Studentship
Proton, alpha and gamma irradiation assisted stress corrosion cracking: understanding the fuel-stainless steel interface
质子、α 和 γ 辐照辅助应力腐蚀开裂:了解燃料-不锈钢界面
  • 批准号:
    2908693
  • 财政年份:
    2027
  • 资助金额:
    $ 6.07万
  • 项目类别:
    Studentship
Field Assisted Sintering of Nuclear Fuel Simulants
核燃料模拟物的现场辅助烧结
  • 批准号:
    2908917
  • 财政年份:
    2027
  • 资助金额:
    $ 6.07万
  • 项目类别:
    Studentship
Assessment of new fatigue capable titanium alloys for aerospace applications
评估用于航空航天应用的新型抗疲劳钛合金
  • 批准号:
    2879438
  • 财政年份:
    2027
  • 资助金额:
    $ 6.07万
  • 项目类别:
    Studentship
Developing a 3D printed skin model using a Dextran - Collagen hydrogel to analyse the cellular and epigenetic effects of interleukin-17 inhibitors in
使用右旋糖酐-胶原蛋白水凝胶开发 3D 打印皮肤模型,以分析白细胞介素 17 抑制剂的细胞和表观遗传效应
  • 批准号:
    2890513
  • 财政年份:
    2027
  • 资助金额:
    $ 6.07万
  • 项目类别:
    Studentship
CDT year 1 so TBC in Oct 2024
CDT 第 1 年,预计 2024 年 10 月
  • 批准号:
    2879865
  • 财政年份:
    2027
  • 资助金额:
    $ 6.07万
  • 项目类别:
    Studentship
Understanding the interplay between the gut microbiome, behavior and urbanisation in wild birds
了解野生鸟类肠道微生物组、行为和城市化之间的相互作用
  • 批准号:
    2876993
  • 财政年份:
    2027
  • 资助金额:
    $ 6.07万
  • 项目类别:
    Studentship

相似海外基金

SBIR Phase II: Innovative Glass Inspection for Advanced Semiconductor Packaging
SBIR 第二阶段:先进半导体封装的创新玻璃检测
  • 批准号:
    2335175
  • 财政年份:
    2024
  • 资助金额:
    $ 6.07万
  • 项目类别:
    Cooperative Agreement
SBIR Phase II: Innovative Two-Phase Cooling with Micro Closed Loop Pulsating Heat Pipes for High Power Density Electronics
SBIR 第二阶段:用于高功率密度电子产品的创新两相冷却微闭环脉动热管
  • 批准号:
    2321862
  • 财政年份:
    2024
  • 资助金额:
    $ 6.07万
  • 项目类别:
    Cooperative Agreement
Innovative Double Patterning Strategies for Integrated Circuit Manufacture
集成电路制造的创新双图案化策略
  • 批准号:
    LP230100313
  • 财政年份:
    2024
  • 资助金额:
    $ 6.07万
  • 项目类别:
    Linkage Projects
An innovative platform using ML/AI to analyse farm data and deliver insights to improve farm performance, increasing farm profitability by 5-10%
An%20innovative%20platform%20using%20ML/AI%20to%20analysis%20farm%20data%20and%20deliver%20insights%20to%20improv%20farm%20performance,%20increasing%20farm%20profitability%20by%205-10%
  • 批准号:
    10093235
  • 财政年份:
    2024
  • 资助金额:
    $ 6.07万
  • 项目类别:
    Collaborative R&D
An innovative urinary drainage system that could reduce NHS CAUTI treatment costs by 10% and increase quality-of-life for men suffering from chronic incontinence
%20创新%20泌尿%20引流%20系统%20%20可以%20减少%20NHS%20CAUTI%20治疗%20成本%20by%2010%%20和%20增加%20生活质量%20为%20男性%20痛苦%20来自%20慢性%20失禁
  • 批准号:
    10094849
  • 财政年份:
    2024
  • 资助金额:
    $ 6.07万
  • 项目类别:
    Collaborative R&D
Techno-economic Feasibility Study of ClimaHtech innovative clean maritime solutions
ClimaHtech 创新清洁海事解决方案的技术经济可行性研究
  • 批准号:
    10098100
  • 财政年份:
    2024
  • 资助金额:
    $ 6.07万
  • 项目类别:
    Collaborative R&D
An innovative international payment collection platform using fintech and FPS technology to support SMBs with international transactions that could cut fees by 83%
An%20innovative%20international%20 payment%20collection%20platform%20using%20fintech%20and%20FPS%20technology%20to%20support%20SMBs%20with%20international%20transactions%20that%20could%20cut%20fees%20by%2083%
  • 批准号:
    10098770
  • 财政年份:
    2024
  • 资助金额:
    $ 6.07万
  • 项目类别:
    Collaborative R&D
Sustaining Innovative Tools to Expand Youth-Friendly HIV Self-Testing (S-ITEST)
维持创新工具以扩大青少年友好型艾滋病毒自我检测 (S-ITEST)
  • 批准号:
    10933892
  • 财政年份:
    2024
  • 资助金额:
    $ 6.07万
  • 项目类别:
Towards innovative and affordable sodium- and zinc-based energy storage systems based on more sustainable and locally-sourced materials (eNargiZinc)
开发基于更可持续和本地采购的材料的创新且经济实惠的钠基和锌基储能系统 (eNargiZinc)
  • 批准号:
    EP/Y03127X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 6.07万
  • 项目类别:
    Research Grant
International Platform on Obstetric Violence (IPOV): an innovative tool for a respectful maternity and childbirth care
国际产科暴力平台(IPOV):尊重孕产妇和分娩护理的创新工具
  • 批准号:
    EP/Y037405/1
  • 财政年份:
    2024
  • 资助金额:
    $ 6.07万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了